The nation of Zimbabwe has declined a substantial American healthcare agreement worth $367m (272 million pounds) over five years because of Washington's request for sensitive data.
The decision came to light after a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
An official spokesperson has since clarified that the US was requesting health data for research and profit while was unwilling to share the resulting advantages from any future treatments.
"We are forced to start the difficult and regrettable task of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged more dialogue to reach a deal suitable to both sides so the country's critical HIV treatment initiative can continue.
Wider Context
This development comes after a similar case in neighbouring Kenya, where a high court blocked a related deal with the US following legal challenges were filed about the safety of citizens' medical information.
Since resuming the presidency last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump claimed its spending was "inefficient" and his government was seeking direct bilateral deals to enhance transparency and accountability.
According to statements, 16 African countries have so far signed these new agreements, representing over $18.3bn of fresh investment.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation could have provided immense advantages for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, without any equivalent guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.
"Put simply, our nation would supply the basic resources for medical research without any assurance that the final treatments would be accessible to our population should a future health crisis emerge."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were upending systems previously set up via the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to manage future pandemics.
"This mechanism is designed to ensure that when a nation contributes its data, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to ongoing dialogue with our US partners on how future collaboration might be designed in a way that respects the sovereignty and dignity of both nations."
Medical Community Response
Medical experts said it recognised the government's concerns, but recommended that talks must proceed considering much of the nation's Aids initiatives were funded by foreign aid.
"Where technical issues exist, such as those relating to information security or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," it said.
The situation highlights the continuing debate between receiving much-needed international aid and protecting a country's data in an ever more interconnected world.